Chemoinformaics analysis of Aristololactam A-II
| Molecular Weight | 265.268 | nRot | 1 |
| Heavy Atom Molecular Weight | 254.18 | nRig | 20 |
| Exact Molecular Weight | 265.074 | nRing | 4 |
| Solubility: LogS | -6.447 | nHRing | 1 |
| Solubility: LogP | 3.848 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 3 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 16 |
| nHA | 3 | APOL | 37.5607 |
| nHD | 2 | BPOL | 14.2093 |
| QED | 0.664 |
| Synth | 2.566 |
| Natural Product Likeliness | 1.259 |
| NR-PPAR-gamma | 0.951 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.139 |
| HIA | 0.01 |
| CACO-2 | -5.042 |
| MDCK | 0.0000106 |
| BBB | 0.078 |
| PPB | 0.947196 |
| VDSS | 0.6 |
| FU | 0.0618021 |
| CYP1A2-inh | 0.982 |
| CYP1A2-sub | 0.879 |
| CYP2c19-inh | 0.262 |
| CYP2c19-sub | 0.137 |
| CYP2c9-inh | 0.634 |
| CYP2c9-sub | 0.858 |
| CYP2d6-inh | 0.703 |
| CYP2d6-sub | 0.278 |
| CYP3a4-inh | 0.389 |
| CYP3a4-sub | 0.103 |
| CL | 2.489 |
| T12 | 0.417 |
| hERG | 0.049 |
| Ames | 0.804 |
| ROA | 0.035 |
| SkinSen | 0.926 |
| Carcinogencity | 0.706 |
| EI | 0.894 |
| Respiratory | 0.825 |
| NR-Aromatase | 0.128 |
| Antiviral | Yes |
| Prediction | 0.691472 |